These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Tantawichien T; Jaijaroensup W; Khawplod P; Sitprija V Clin Infect Dis; 2001 Nov; 33(10):E122-4. PubMed ID: 11641838 [TBL] [Abstract][Full Text] [Related]
3. Intradermal rabies vaccines for human post-exposure treatment. Bull World Health Organ; 1993; 71(6):805, 809-10. PubMed ID: 8313499 [No Abstract] [Full Text] [Related]
4. Intradermal regimens for rabies postexposure prophylaxis: more confusion. Warrell MJ; Warrell DA Clin Infect Dis; 2002 Jul; 35(2):213-5; author reply 215. PubMed ID: 12087534 [No Abstract] [Full Text] [Related]
5. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
6. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization. Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Matha IS; Salunke SR Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086 [TBL] [Abstract][Full Text] [Related]
10. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers". Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424 [TBL] [Abstract][Full Text] [Related]
11. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
12. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pengsaa K; Limkittikul K; Sabchareon A; Ariyasriwatana C; Chanthavanich P; Attanath P; Malerczyk C Pediatr Infect Dis J; 2009 Apr; 28(4):335-7. PubMed ID: 19333080 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against rabies. Wilde H; Hemachudha T N Engl J Med; 2005 Apr; 352(15):1608-10; author reply 1608-10. PubMed ID: 15832456 [No Abstract] [Full Text] [Related]
14. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893 [TBL] [Abstract][Full Text] [Related]
15. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Khawplod P; Wilde H; Tepsumethanon S; Limusanno S; Tantawichien T; Chomchey P; Ayuthaya AB; Wangroonsarb Y Clin Infect Dis; 2002 Dec; 35(12):1562-5. PubMed ID: 12471579 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against rabies. Van den Enden E N Engl J Med; 2005 Apr; 352(15):1608-10; author reply 1608-10. PubMed ID: 15832455 [No Abstract] [Full Text] [Related]
17. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097 [TBL] [Abstract][Full Text] [Related]
18. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972 [TBL] [Abstract][Full Text] [Related]
19. Simulated post-exposure rabies vaccination: comments on article by Madhusudana et al. Wilde H; Khawplod P; Hemachudha T Int J Infect Dis; 2004 Nov; 8(6):374-5; author reply 376. PubMed ID: 15494259 [No Abstract] [Full Text] [Related]
20. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans. Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]